IceCure Medical
Manufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7 Ha'eshel St, Caesarea, Haifa, 3079504,...Phone Number
+972 46230333Website
www.icecure-medical.comRevenue
<$5 MillionStock Symbol
ICCMIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About IceCure Medical
IceCure Medical Ltd. is an Israeli medical device company that develops, manufactures, and markets minimally-invasive cryoablation systems used to destroy benign and malignant tumors by freezing them. Its flagship ProSense liquid-nitrogen-based technology offers a safe and effective alternative to traditional surgical tumor removal. The company's products are used worldwide in a range of clinical applications across women's health and interventional oncology, with regulatory approvals in multiple regions and a growing global distribution network. IceCure was incorporated in 2006 and is headquartered in Caesarea, Israel.Explore more
IceCure Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IceCure Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if IceCure Medical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at IceCure Medical
Check if IceCure Medical has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once IceCure Medical has new funding data
Earning: See what the market has to say on IceCure Medical recently announced quarterly report
Product Launch: Get notified when IceCure Medical launches new products
Click to see if IceCure Medical had a recent Job posting/layoffs
IceCure Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
IceCure Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IceCure Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IceCure Medical.
IceCure Medical financials insights
Gather financial insights about IceCure Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$6.1M
IceCure Medical Tech Stack
A closer look at the technologies used by IceCure Medical
Most Recent Scoops
Person-Based
Hiring Plans, Sales
New Hire
Executive Move
Executive Moves, New Hire
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Earnings
Event
Earnings, Events, Finance
IceCure Medical News & Media
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
The Company is advancing commercial execution and expanding its U.S. commercial footprint through approximately 70% growth in its active installed base following U.S. Food and Drug Administration's ("FDA") clearance, driving long-term value creation and supported by a strong cash position...IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signing both an agreement and receiving IRB approval The site will be led by breast surgeon, Dr. Dennis Holmes, MD, FACS, a recognized leader in breast cancer cryoablation CAESAREA, Israel,...IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026
CAESAREA, Israel, Aug. 5, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it will...IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
The petition by The Society of Interventional Oncology (SIO) includes adding criteria for patients aged 50-69 who are poor surgical candidates or who decline surgery in the National Comprehensive Cancer Network (NCCN) treatment guidelines, expanding the current eligible population of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IceCure Medical
Sign Up For FreeTo access detailed company insights
IceCure Medical Ltd. is an Israeli medical device company that develops, manufactures, and markets minimally-invasive cryoablation systems used to destroy benign and malignant tumors by freezing them. Its flagship ProSense liquid-nitrogen-based technology offers a safe and effective alternative to traditional surgical tumor removal. The company's p... Read More
